Extramedullary Disease in Multiple Myeloma Clinical Trials

3 clinical trials for Extramedullary Disease in Multiple Myeloma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD" — RECRUITING · PHASE2
• Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease — RECRUITING · PHASE2
• External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease — RECRUITING · PHASE1

Refine this search